103 related articles for article (PubMed ID: 11920574)
1. T lymphocyte expression of thrombospondin-1 and adhesion to extracellular matrix components.
Li SS; Ivanoff A; Bergström SE; Sandström A; Christensson B; van Nerven J; Holgersson J; Hauzenberger D; Arencibia I; Sundqvist KG
Eur J Immunol; 2002 Apr; 32(4):1069-79. PubMed ID: 11920574
[TBL] [Abstract][Full Text] [Related]
2. Regulation of T-lymphocyte motility, adhesion and de-adhesion by a cell surface mechanism directed by low density lipoprotein receptor-related protein 1 and endogenous thrombospondin-1.
Talme T; Bergdahl E; Sundqvist KG
Immunology; 2014 Jun; 142(2):176-92. PubMed ID: 24877199
[TBL] [Abstract][Full Text] [Related]
3. Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesion.
Li SS; Liu Z; Uzunel M; Sundqvist KG
Blood; 2006 Nov; 108(9):3112-20. PubMed ID: 16835379
[TBL] [Abstract][Full Text] [Related]
4. T-cell regulation through a basic suppressive mechanism targeting low-density lipoprotein receptor-related protein 1.
Panezai J; Bergdahl E; Sundqvist KG
Immunology; 2017 Oct; 152(2):308-327. PubMed ID: 28580688
[TBL] [Abstract][Full Text] [Related]
5. A cytokine-controlled mechanism for integrated regulation of T-lymphocyte motility, adhesion and activation.
Bergström SE; Bergdahl E; Sundqvist KG
Immunology; 2013 Dec; 140(4):441-55. PubMed ID: 23866045
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of surface and intracellular protein expression by T cells after stimulation in the presence of monensin or brefeldin A.
O'Neil-Andersen NJ; Lawrence DA
Clin Diagn Lab Immunol; 2002 Mar; 9(2):243-50. PubMed ID: 11874859
[TBL] [Abstract][Full Text] [Related]
7. Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.
Bergström SE; Uzunel M; Talme T; Bergdahl E; Sundqvist KG
Immunology; 2015 Apr; 144(4):687-703. PubMed ID: 25393517
[TBL] [Abstract][Full Text] [Related]
8. Autocrine regulation of T cell motility by calreticulin-thrombospondin-1 interaction.
Li SS; Forslöw A; Sundqvist KG
J Immunol; 2005 Jan; 174(2):654-61. PubMed ID: 15634883
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 expression in breast cancer: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
Ioachim E; Damala K; Tsanou E; Briasoulis E; Papadiotis E; Mitselou A; Charhanti A; Doukas M; Lampri L; Arvanitis DL
Histol Histopathol; 2012 Feb; 27(2):209-16. PubMed ID: 22207555
[TBL] [Abstract][Full Text] [Related]
10. A CD26-controlled cell surface cascade for regulation of T cell motility and chemokine signals.
Liu Z; Christensson M; Forslöw A; De Meester I; Sundqvist KG
J Immunol; 2009 Sep; 183(6):3616-24. PubMed ID: 19687096
[TBL] [Abstract][Full Text] [Related]
11. Trimeric assembly of the C-terminal region of thrombospondin-1 or thrombospondin-2 is necessary for cell spreading and fascin spike organisation.
Anilkumar N; Annis DS; Mosher DF; Adams JC
J Cell Sci; 2002 Jun; 115(Pt 11):2357-66. PubMed ID: 12006620
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of TGF-beta1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells.
Motegi K; Harada K; Ohe G; Jones SJ; Ellis IR; Crouch DH; Schor SL; Schor AM
Exp Cell Res; 2008 Aug; 314(13):2323-33. PubMed ID: 18555217
[TBL] [Abstract][Full Text] [Related]
13. Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells.
Miyajima-Uchida H; Hayashi H; Beppu R; Kuroki M; Fukami M; Arakawa F; Tomita Y; Kuroki M; Oshima K
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):561-7. PubMed ID: 10670489
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of trichostatin A-induced antiangiogenesis by small-interfering RNA for thrombospondin-1.
Kang JH; Kim SA; Chang SY; Hong S; Hong KJ
Exp Mol Med; 2007 Jun; 39(3):402-11. PubMed ID: 17603295
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate and its therapeutic antagonists caffeine and theophylline, target a motogenic T-cell mechanism driven by thrombospondin-1 (TSP-1).
Talme T; Bergdahl E; Sundqvist KG
Eur J Immunol; 2016 May; 46(5):1279-90. PubMed ID: 26909742
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of thrombospondin and cellular fibronectin during remodeling in proliferative glomerulonephritis.
Barnes JL; Mitchell RJ; Kanalas JJ; Barnes VL
J Histochem Cytochem; 1999 Apr; 47(4):533-44. PubMed ID: 10082755
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of thrombospondin-1 in myelinating glial cells of the central nervous system.
Scott-Drew S; ffrench-Constant C
J Neurosci Res; 1997 Oct; 50(2):202-14. PubMed ID: 9373030
[TBL] [Abstract][Full Text] [Related]
19. Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo.
Bongrazio M; Da Silva-Azevedo L; Bergmann EC; Baum O; Hinz B; Pries AR; Zakrzewicz A
Int J Immunopathol Pharmacol; 2006; 19(1):35-48. PubMed ID: 16569344
[TBL] [Abstract][Full Text] [Related]
20. Soluble thrombospondin-1 suppresses T cell proliferation and enhances IL-10 secretion by antigen presenting cells stimulated with phytohemagglutinin.
Beppu R; Nakamura K; Miyajima-Uchida H; Kuroki M; Khare PD; Yamauchi Y; Yamashita Y; Shirakusa T; Kuroki M
Immunol Invest; 2001 May; 30(2):143-56. PubMed ID: 11465671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
